James Anderson is the Chair of the INTREPID Alliance and the Executive Director of Global Health at the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), a leading global organization representing pharmaceutical companies. In his role at IFPMA, James spearheads efforts to address critical global health challenges, including antimicrobial resistance, pandemic preparedness, and non-communicable diseases.

As debate continues over the cost and sustainability of GLP-1 [...]

Axplora has announced a €6.5 million investment at its Vizag [...]

Ethris has dosed the first patient in a Phase 2a [...]

Nucleus Network has acquired UK-based Hammersmith Medicines Research (HMR), a [...]

A new investigational HIV vaccine candidate, GRAdHIVNE1, has entered Phase [...]

New AI platform designed to support faster discovery, better study [...]

Investment led by aMoon will support US and EU commercialisation [...]

OMNY Health has reached a major milestone, announcing that its [...]

In a significant shift for Alzheimer’s care, the Alzheimer’s Association [...]